rdf:type |
|
lifeskim:mentions |
umls-concept:C0008976,
umls-concept:C0016360,
umls-concept:C0021734,
umls-concept:C0023413,
umls-concept:C0034656,
umls-concept:C0041700,
umls-concept:C0043227,
umls-concept:C0205179,
umls-concept:C1518904,
umls-concept:C1527249,
umls-concept:C1551807,
umls-concept:C1556038,
umls-concept:C1563350,
umls-concept:C1563351,
umls-concept:C1883712
|
pubmed:issue |
8
|
pubmed:dateCreated |
1996-9-6
|
pubmed:abstractText |
To determine the effects of interferon alpha-2a (IFN alpha) on the efficacy and toxicity of fluorouracil (FUra) and leucovorin (LV) in patients with advanced colorectal cancer.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0732-183X
|
pubmed:author |
pubmed-author:CunninghamDD,
pubmed-author:DuffyA MAM,
pubmed-author:HarperP GPG,
pubmed-author:JamesR DRD,
pubmed-author:KerrD JDJ,
pubmed-author:LedermannJ AJA,
pubmed-author:McAdamW AWA,
pubmed-author:NeoptolemosJ PJP,
pubmed-author:NicholsonMM,
pubmed-author:PerrenT JTJ,
pubmed-author:SeymourM TMT,
pubmed-author:SlevinM LML,
pubmed-author:StenningS PSP,
pubmed-author:StephensR JRJ,
pubmed-author:TaylorII
|
pubmed:issnType |
Print
|
pubmed:volume |
14
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2280-8
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:8708718-Adult,
pubmed-meshheading:8708718-Aged,
pubmed-meshheading:8708718-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:8708718-Colorectal Neoplasms,
pubmed-meshheading:8708718-Combined Modality Therapy,
pubmed-meshheading:8708718-Disease-Free Survival,
pubmed-meshheading:8708718-Female,
pubmed-meshheading:8708718-Fluorouracil,
pubmed-meshheading:8708718-Great Britain,
pubmed-meshheading:8708718-Humans,
pubmed-meshheading:8708718-Interferon-alpha,
pubmed-meshheading:8708718-Leucovorin,
pubmed-meshheading:8708718-Male,
pubmed-meshheading:8708718-Middle Aged,
pubmed-meshheading:8708718-Palliative Care,
pubmed-meshheading:8708718-Quality of Life,
pubmed-meshheading:8708718-Recombinant Proteins,
pubmed-meshheading:8708718-Remission Induction,
pubmed-meshheading:8708718-Survival Rate
|
pubmed:year |
1996
|
pubmed:articleTitle |
Randomized trial assessing the addition of interferon alpha-2a to fluorouracil and leucovorin in advanced colorectal cancer. Colorectal Cancer Working Party of the United Kingdom Medical Research Council.
|
pubmed:affiliation |
Colorectal Cancer Working Party, United Kingdom Medical Research Council, London, United Kingdom. seymour@thecafe.co.uk
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|